Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000081:Acetamides / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001923:Brain Chemistry / Q000187:drug effects; D003000:Clonidine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects*; D004298:Dopamine / Q000378:metabolism*; D006834:Hydrazines / Q000494:pharmacology; D007980:Levodopa / Q000031:analogs & derivatives / Q000494:pharmacology*; D008750:Methyldopa / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D009068:Movement / Q000187:drug effects; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D009655:Octopamine / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug; D012018:Reflex / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism; D013268:Stimulation, Chemical; D014439:Tyramine / Q000494:pharmacology; D014443:Tyrosine / Q000494:pharmacology
D000081:Acetamides; D006834:Hydrazines; D008781:Methyltyrosines; D011955:Receptors, Drug; D009655:Octopamine; D014443:Tyrosine; D007980:Levodopa; D008750:Methyldopa; D012110:Reserpine; D006916:5-Hydroxytryptophan; D003000:Clonidine; D001058:Apomorphine; D009526:Nialamide; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine